MST1/2 Balance Immune Activation and Tolerance by Orchestrating Adhesion, Transcription, and Organelle Dynamics in Lymphocytes.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 29 12 2019
accepted: 31 03 2020
entrez: 22 5 2020
pubmed: 22 5 2020
medline: 18 3 2021
Statut: epublish

Résumé

The STE20-like serine/threonine kinases MST1 and MST2 (MST1/2) are mammalian homologs of Hippo in flies. MST1/2 regulate organ size by suppressing the transcription factor YAP, which promotes proliferation. MST1 is predominantly expressed in immune cells, where it plays distinct roles. Here, we review the functions of MST1/2 in immune cells, uncovered by a series of recent studies, and discuss the connection between MST1/2 function and immune responses. MST1/2 regulate lymphocyte development, trafficking, survival, and antigen recognition by naive T cells. MST1/2 also regulate the function of regulatory T cells and effector T cell differentiation, thus acting to balance immune activation and tolerance. Interestingly, MST1/2 elicit these functions not by the "canonical" Hippo pathway, but by the non-canonical Hippo pathway or alternative pathways. In these pathways, MST1/2 regulates cellular processes relating to immune response, such as chemotaxis, cell adhesion, immunological synapse, gene transcriptions. Recent advances in our understanding of the molecular mechanisms of these processes have revealed important roles of MST1/2 in regulating cytoskeleton remodeling, integrin activation, and vesicular transport in lymphocytes. We discuss the significance of the MST1/2 signaling in lymphocytes in the regulation of organelle dynamics.

Identifiants

pubmed: 32435241
doi: 10.3389/fimmu.2020.00733
pmc: PMC7218056
doi:

Substances chimiques

Intracellular Signaling Peptides and Proteins 0
STK4 protein, human EC 2.7.1.11
Protein Serine-Threonine Kinases EC 2.7.11.1
STK3 protein, human EC 2.7.11.1
Serine-Threonine Kinase 3 EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

733

Informations de copyright

Copyright © 2020 Ueda, Kondo and Kinashi.

Références

Genetics. 2000 Dec;156(4):1817-28
pubmed: 11102376
J Immunol. 2016 Sep 1;197(5):1683-91
pubmed: 27465533
Nat Commun. 2012;3:1098
pubmed: 23033074
Genes Cells. 2019 Jul;24(7):485-495
pubmed: 31125466
Science. 2002 Nov 15;298(5597):1395-401
pubmed: 12376594
Nat Cell Biol. 2003 Oct;5(10):914-20
pubmed: 14502294
Curr Biol. 2015 Feb 2;25(3):296-305
pubmed: 25601544
Blood. 2012 Apr 12;119(15):3450-7
pubmed: 22294732
Nat Cell Biol. 2003 Oct;5(10):921-7
pubmed: 14502295
Nat Commun. 2017 Jan 09;8:13946
pubmed: 28067314
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10113-8
pubmed: 18635688
FEBS Lett. 2016 Jan;590(1):68-75
pubmed: 26787462
J Biol Chem. 2011 Mar 4;286(9):6940-5
pubmed: 21212262
Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):E1312-20
pubmed: 22042863
J Biol Chem. 2015 Dec 25;290(52):30762-70
pubmed: 26538561
J Cell Biol. 2004 Oct 25;167(2):327-37
pubmed: 15504914
Nat Immunol. 2009 Aug;10(8):823-30
pubmed: 19543275
Blood. 2001 Oct 1;98(7):2108-15
pubmed: 11567997
Cell Immunol. 2010;266(1):7-13
pubmed: 20864093
Mol Cell Biol. 2017 Mar 31;37(8):
pubmed: 28137909
Immunity. 2018 Nov 20;49(5):899-914.e6
pubmed: 30413360
PLoS One. 2014 Aug 18;9(8):e105561
pubmed: 25133611
Proc Natl Acad Sci U S A. 2006 May 2;103(18):7006-11
pubmed: 16641096
PLoS One. 2012;7(8):e44010
pubmed: 22952854
Front Physiol. 2013 Jun 20;4:147
pubmed: 23801966
J Clin Invest. 2016 Nov 1;126(11):4125-4139
pubmed: 27701149
J Immunol. 2018 Jun 15;200(12):4012-4023
pubmed: 29703862
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5663-7
pubmed: 10318941
J Immunol. 2017 Jun 15;198(12):4639-4651
pubmed: 28515282
Blood. 2010 Dec 23;116(26):5907-18
pubmed: 20923969
Front Immunol. 2018 Dec 04;9:2852
pubmed: 30568657
PLoS One. 2013 Sep 09;8(9):e73874
pubmed: 24040101
Nat Immunol. 2003 Aug;4(8):741-8
pubmed: 12845325
Curr Biol. 2008 Dec 9;18(23):1889-95
pubmed: 19062280
Curr Biol. 2009 Nov 3;19(20):1692-702
pubmed: 19836237
Sci Rep. 2018 Jan 17;8(1):942
pubmed: 29343826
Nat Immunol. 2017 Jul;18(7):800-812
pubmed: 28504697
Nat Commun. 2017 Nov 23;8(1):1744
pubmed: 29170462
Eur J Immunol. 1995 Jul;25(7):2034-41
pubmed: 7621877
Nat Commun. 2015 Oct 05;6:8357
pubmed: 26437443
J Cell Biol. 2019 Jun 3;218(6):1799-1809
pubmed: 30988001
EMBO J. 2009 May 6;28(9):1319-31
pubmed: 19339990
Neuron. 2012 Mar 22;73(6):1127-42
pubmed: 22445341
Blood. 2012 Jan 12;119(2):465-8
pubmed: 22110250
Blood. 2010 Feb 4;115(5):965-74
pubmed: 19996091
J Clin Immunol. 2016 Feb;36(2):117-22
pubmed: 26801501
Sci Signal. 2015 Oct 06;8(397):ra100
pubmed: 26443704
Nat Immunol. 2006 Sep;7(9):919-28
pubmed: 16892067
Cancer Cell. 2009 Nov 6;16(5):425-38
pubmed: 19878874
Nat Rev Immunol. 2011 Jun 24;11(7):469-77
pubmed: 21701522
Biochem Biophys Res Commun. 2017 Jul 15;489(1):56-62
pubmed: 28527887
J Immunol. 2009 Sep 15;183(6):3865-72
pubmed: 19692642
Cell. 2003 Aug 22;114(4):445-56
pubmed: 12941273
Nat Cell Biol. 2015 Jan;17(1):81-94
pubmed: 25531777
J Cell Biol. 2012 Oct 15;199(2):317-30
pubmed: 23045549
Blood. 2012 Jan 19;119(3):777-85
pubmed: 22117043
Front Immunol. 2018 Oct 17;9:2393
pubmed: 30386341
Blood. 2015 Dec 17;126(25):2704-12
pubmed: 26337492
Cell. 2006 Jun 2;125(5):987-1001
pubmed: 16751106
Science. 2002 Jul 19;297(5580):409-12
pubmed: 12130787
PLoS One. 2014 May 22;9(5):e98151
pubmed: 24852423
Front Immunol. 2015 Nov 18;6:586
pubmed: 26635800
J Immunol. 2014 Feb 15;192(4):1525-35
pubmed: 24453252
Immunity. 2010 Apr 23;32(4):541-56
pubmed: 20346707
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20321-6
pubmed: 19073936
PLoS One. 2009 Nov 24;4(11):e8011
pubmed: 19956688
Front Immunol. 2018 Feb 20;9:307
pubmed: 29515593
J Immunol. 2011 Sep 1;187(5):2702-10
pubmed: 21795599
J Exp Med. 2012 Apr 9;209(4):741-59
pubmed: 22412158
Nat Immunol. 2010 Jul;11(7):618-27
pubmed: 20467422
Blood. 2018 Dec 27;132(26):2754-2762
pubmed: 30442677
Cell. 2003 Aug 22;114(4):457-67
pubmed: 12941274
Nature. 2006 Sep 14;443(7108):210-3
pubmed: 16906135
Trends Cell Biol. 2014 Jan;24(1):61-72
pubmed: 24119664
Nat Immunol. 2004 Jul;5(7):713-20
pubmed: 15184895
Immunity. 2010 Dec 14;33(6):890-904
pubmed: 21167754
EMBO J. 2009 Dec 16;28(24):3879-92
pubmed: 19875983
Elife. 2018 Sep 06;7:
pubmed: 30187863
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):E2223-9
pubmed: 22745171
J Cell Biol. 2011 Feb 21;192(4):663-74
pubmed: 21339332
Blood. 2012 Apr 12;119(15):3458-68
pubmed: 22174160
Sci Signal. 2014 Jul 29;7(336):ra72
pubmed: 25074980
Curr Opin Immunol. 2008 Apr;20(2):149-57
pubmed: 18434123
J Exp Med. 2002 Jul 1;196(1):65-75
pubmed: 12093871
Nat Immunol. 2004 Oct;5(10):1045-51
pubmed: 15361866
Nat Rev Immunol. 2016 Mar;16(3):193-201
pubmed: 26852928

Auteurs

Yoshihiro Ueda (Y)

Department of Molecular Genetics, Institute of Biomedical Science, Kansai Medical University, Hirakata, Japan.

Naoyuki Kondo (N)

Department of Molecular Genetics, Institute of Biomedical Science, Kansai Medical University, Hirakata, Japan.

Tatsuo Kinashi (T)

Department of Molecular Genetics, Institute of Biomedical Science, Kansai Medical University, Hirakata, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH